StockData
BioCardia, Inc. logo

BioCardia, Inc. (BCDA) stock

BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.77−0.02 (-2.06%)

Close on Nov 18, 2026Market cap $11.69MP/E –Yield –

BioCardia gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

BioCardia's gross profit for the twelve months ending Dec 31, 2021 was $1.02M, up 619.9% year over year. For fiscal 2021 it was $1.02M, up 619.9% from the year before. The highest annual figure on record is $1.02M in fiscal 2021.

Annual gross profit

PeriodPeriod endValueChange
FY2021Dec 31, 2021$1.02M+619.9%
FY2020Dec 31, 2020$141.00K-59.9%
FY2019Dec 31, 2019$352.00K+225.9%
FY2018Dec 31, 2018$108.00K–
FY2017Dec 31, 2017-$211.00K–
FY2016Dec 31, 2016-$170.00K–
FY2015Dec 31, 2015-$157.00K-353.2%
FY2012Dec 31, 2012$62.00K+416.7%
FY2011Dec 31, 2011$12.00K–
FY2010Dec 31, 2010$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$79.00K+132.4%
Q3 FY2021Sep 30, 2021$821.00K+2940.7%
Q2 FY2021Jun 30, 2021$69.00K+102.9%
Q4 FY2020Dec 31, 2020$46.00K-74.2%
Q3 FY2020Sep 30, 2020$34.00K-80.0%
Q2 FY2020Jun 30, 2020$27.00K–
Q1 FY2020Mar 31, 2020$34.00K-69.1%
Q4 FY2019Dec 31, 2019$178.00K–
Q3 FY2019Sep 30, 2019$170.00K–
Q2 FY2019Jun 30, 2019-$105.00K-201.0%
Q1 FY2019Mar 31, 2019$110.00K+161.9%
Q4 FY2018Dec 31, 2018-$13.00K–
Q3 FY2018Sep 30, 2018-$25.00K–
Q2 FY2018Jun 30, 2018$104.00K–
Q1 FY2018Mar 31, 2018$42.00K–
Q4 FY2017Dec 31, 2017-$65.00K–
Q3 FY2017Sep 30, 2017-$17.00K–
Q2 FY2017Jun 30, 2017-$91.00K–
Q1 FY2017Mar 31, 2017-$38.00K–
Q4 FY2016Dec 31, 2016-$31.00K–
Q3 FY2016Sep 30, 2016-$79.00K–

More BioCardia figures

See a number that looks wrong?